Articles by Alexis Pellek - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Alexis Pellek

Alexis Pellek

Assistant Editor, Pharmaceutical Technology

See Alexis Pellek's bio page.

Articles
Q&A: Thin-layer Chromatography Kits Screen for Counterfeits in Developing Countries
August 2, 2011

Thomas P. Layloff describes the advantages of using thin-layer chromatography methods for counterfeit detection. This article contains bonus online material.

Chemical Confirmation
August 2, 2011

Analytical detection techniques help combat counterfeit drugs.

Rogue Pharmacies
February 2, 2011

Government and private sector efforts take on counterfeit drugs online.

Securing Pharmaceutical Glass Containers
February 2, 2011

Anticounterfeiting solutions for vials and syringes.

FDA Gains Food Recall Authority, Drugs Could be Next
January 6, 2011

FDA received the authority to mandate recalls of food under a new food-safety bill. Efforts are underway in the House to grant the agency this power for pharmaceuticals as well.

Hope for an AIDS Vaccine
December 2, 2010

World AIDS Day 2010 reminds us that prevention and hope can help fight the disease.

Authentication and Pharmaceutical Protection: An Industry Roundtable
September 2, 2010

PharmTech talked to anticounterfeiting experts to discuss terrorism as a source of counterfeit products.

More J&J Quality Problems Revealed with New Recall
August 26, 2010

J&J issued a recall of millions of its daily disposable contact lenses, 1 Day Acuvue, sold in Japan and more than two dozen other Asian and European countries, according to a report from the Associated Press.

Developing siRNA Therapies: A Technical Forum
August 2, 2010

Pharmaceutical Technology talked to experts in siRNA-drug development to gain insight into the characteristics, processes, and challenges of this class of therapeutics.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here